10x Genomics, Inc. revenue decreases to $134.28 million in quarter ended Mar 31, 2023 from previous quarter
By USInMinutes - May 04, 2023, 05:13 PM ET
Last Updated - Jul 18, 2023, 03:39 PM EDT
Key fundamental financials
loss of $50.75 million
Revenue of $134.28 million
Current Reporting
Revenue
Net Income
Profit/Loss
Mar 2023
$134.28 million
$50.75 million
loss
Sep 2022
$131,072
$41,914
loss
Jun 2022
$114.61 million
$64.46 million
loss
10x Genomics, Inc. [TXG] has reported $50.75 million loss for the fiscal quarter ending Mar 31, 2023.
Revenue for the quarter was $134.28 million with operating income of $51.99 million.
The Pleasanton, California (CA)-based company operating in the laboratory analytical instruments sector has total shareholders equity of $802.38 million.
